Sumitomo Mitsui DS Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,267
| Closed | -$514K | – | 784 |
|
|
2024
Q1 | $514K | Hold |
4,267
| – | – | 0.01% | 687 |
|
|
2023
Q4 | $525K | Hold |
4,267
| – | – | 0.01% | 701 |
|
|
2023
Q3 | $552K | Sell |
4,267
-14
| -0.3% | -$1.86K | 0.01% | 667 |
|
|
2023
Q2 | $531K | Sell |
4,281
-14
| -0.3% | -$1.88K | 0.01% | 669 |
|
|
2023
Q1 | $628K | Hold |
4,295
| – | – | 0.01% | 634 |
|
|
2022
Q4 | $684K | Buy |
4,295
+23
| +0.5% | +$3.37K | 0.01% | 602 |
|
|
2022
Q3 | $569K | Buy |
4,272
+39
| +0.9% | +$5.93K | 0.01% | 608 |
|
|
2022
Q2 | $660K | Buy |
4,233
+1,485
| +54% | +$229K | 0.02% | 581 |
|
|
2022
Q1 | $428K | Sell |
2,748
-127
| -4% | -$18.4K | 0.01% | 681 |
|
|
2021
Q4 | $366K | Buy |
2,875
+15
| +0.5% | +$1.97K | 0.01% | 708 |
|
|
2021
Q3 | $372K | Sell |
2,860
-24
| -0.8% | -$3.63K | 0.01% | 690 |
|
|
2021
Q2 | $512K | Sell |
2,884
-14
| -0.5% | -$2.42K | 0.01% | 666 |
|
|
2021
Q1 | $476K | Buy |
2,898
+25
| +0.9% | +$4.11K | 0.01% | 647 |
|
|
2020
Q4 | $474K | Sell |
2,873
-25
| -0.9% | -$3.72K | 0.01% | 623 |
|
|
2020
Q3 | $413K | Hold |
2,898
| – | – | 0.01% | 604 |
|
|
2020
Q2 | $319K | Hold |
2,898
| – | – | 0.01% | 642 |
|
|
2020
Q1 | $289K | Buy |
2,898
+21
| +0.7% | +$2.71K | 0.01% | 605 |
|
|
2019
Q4 | $429K | Buy |
2,877
+70
| +2% | +$9.53K | 0.01% | 623 |
|
|
2019
Q3 | $359K | Hold |
2,807
| – | – | 0.01% | 616 |
|
|
2019
Q2 | $400K | Sell |
2,807
-923
| -25% | -$124K | 0.02% | 594 |
|
|
2019
Q1 | $533K | Hold |
3,730
| – | – | 0.01% | 659 |
|
|
2018
Q4 | $462K | Hold |
3,730
| – | – | 0.01% | 650 |
|
|
2018
Q3 | $627K | Hold |
3,730
| – | – | 0.01% | 645 |
|
|
2018
Q2 | $642K | Hold |
3,730
| – | – | 0.01% | 632 |
|
|
2018
Q1 | $563K | Sell |
3,730
-439
| -11% | -$64.4K | 0.01% | 663 |
|
|
2017
Q4 | $561K | Sell |
4,169
-124
| -3% | -$17.2K | 0.01% | 684 |
|
|
2017
Q3 | $627K | Hold |
4,293
| – | – | 0.01% | 614 |
|
|
2017
Q2 | $667K | Sell |
4,293
-617
| -13% | -$94.4K | 0.01% | 598 |
|
|
2017
Q1 | $712K | Buy |
4,910
+707
| +17% | +$92.1K | 0.01% | 594 |
|
|
2016
Q4 | $458K | Sell |
4,203
-72
| -2% | -$8.02K | 0.01% | 659 |
|
|
2016
Q3 | $519K | Hold |
4,275
| – | – | 0.01% | 612 |
|
|
2016
Q2 | $604K | Buy |
4,275
+82
| +2% | +$12.1K | 0.02% | 539 |
|
|
2016
Q1 | $547K | Buy |
4,193
+61
| +1% | +$7.59K | 0.02% | 582 |
|
|
2015
Q4 | $580K | Hold |
4,132
| – | – | 0.02% | 555 |
|
|
2015
Q3 | $548K | Sell |
4,132
-299
| -7% | -$51.5K | 0.02% | 568 |
|
|
2015
Q2 | $780K | Sell |
4,431
-32
| -0.7% | -$5.75K | 0.02% | 505 |
|
|
2015
Q1 | $771K | Sell |
4,463
-364
| -8% | -$62.5K | 0.02% | 536 |
|
|
2014
Q4 | $790K | Buy |
+4,827
| New | +$801K | 0.02% | 540 |
|
Other funds holding JAZZ
VPC
PCM
Sumitomo Mitsui DS Asset Management's JAZZ Position: Q2 2024 in Review
Sumitomo Mitsui DS Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 4,267 shares — an estimated $514K sold.
Sumitomo Mitsui DS Asset Management first reported a position in JAZZ in Q4 2014 and held it in 38 quarters. The position peaked at $790K in Q4 2014. 456 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.
- Sumitomo Mitsui DS Asset Management reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Sumitomo Mitsui DS Asset Management sold 4,267 Jazz Pharmaceuticals shares in Q2 2024, an estimated $514K.
- Sumitomo Mitsui DS Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 38 quarters.
- Sumitomo Mitsui DS Asset Management's Jazz Pharmaceuticals position peaked at $790K in Q4 2014.
- 456 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2024, filed 30 Jul 2024.